gptkbp:instanceOf
|
gptkb:drug
recombinant human follicle-stimulating hormone
|
gptkbp:administeredBy
|
subcutaneous injection
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
|
gptkbp:ATCCode
|
gptkb:G03GA05
|
gptkbp:CASNumber
|
9002-68-0
|
gptkbp:contraindication
|
primary ovarian failure
ovarian enlargement
uncontrolled thyroid or adrenal dysfunction
|
https://www.w3.org/2000/01/rdf-schema#label
|
follitropin alfa
|
gptkbp:indication
|
anovulation
controlled ovarian hyperstimulation
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:macromoleculeType
|
gptkb:protein
|
gptkbp:marketedAs
|
gptkb:Gonal-f
|
gptkbp:mechanismOfAction
|
stimulates ovarian follicular growth
stimulates spermatogenesis
|
gptkbp:pregnancyCategory
|
gptkb:X_(US)
|
gptkbp:producedBy
|
gptkb:EMD_Serono
gptkb:Merck_Serono
|
gptkbp:proteinSequence
|
recombinant DNA technology
|
gptkbp:routeOfAdministration
|
subcutaneous
|
gptkbp:sideEffect
|
abdominal pain
headache
injection site reaction
ovarian hyperstimulation syndrome
|
gptkbp:UNII
|
QX8ZV8I382
|
gptkbp:usedFor
|
assisted reproductive technology
treatment of infertility
ovarian stimulation
|
gptkbp:bfsParent
|
gptkb:Gonal-f
gptkb:Bemfola
gptkb:Ovaleap
gptkb:Pergoveris
|
gptkbp:bfsLayer
|
6
|